Since 2022, Cochrane has bestowed new lifetime and emeritus memberships, recognizing the extraordinary contributions of individuals who have made an exceptional, long-standing contribution to Cochrane’s work and leadership. Three Cochrane Infectious Diseases Group (CIDG) Editors were recognized at the 2023 Cochrane Colloquium for their outstanding work.

During January 2024, the CIDG contributed to one new Cochrane protocol and one new review published in Issue 1, 2024 of the Cochrane Database of Systematic Reviews, and one publication in

Key messagesTwo doses of the whole‐cell plus recombinant vaccine (WC‐rBS vaccine (Dukoral)), with or without a booster dose, reduces cases of cholera for two years.

The weeks of 2023 continue to fly by! As the end of 2023 approaches, the Cochrane Infectious Diseases Group (CIDG) editorial base in Liverpool conveys thanks to its readers, authors, referees, Editors, and READ-It Partners for their continued support to the CIDG’s work. In this newsletter we reflect on the past 12 months at the CIDG.

During November 2023, the CIDG contributed to one new Cochrane protocol and one updated review in Issue 11, 2023 of the Cochrane Database of Systematic Reviews.

Is the combination of nirmatrelvir plus ritonavir effective for treating or preventing COVID‐19?Key messagesNirmatrelvir/ritonavir (Paxlovid) is evaluated for the treatment of coronavirus disease 2019 (COVID‐19).

Once the mainstay of child health clinics in low- and middle-income countries (LMICs), a new Cochrane Review of growth monitoring and promotion (GMP) shows the evidence to support its use is limited and uncertain.

The annual Cochrane Colloquium brings people together from around the world to discuss research into important global health questions and promote evidence-informed health care. The 2023 theme, ‘Forward together for trusted evidence’, explored the challenges for the future around trustworthiness of healthcare data and information whilst also celebrating 30 years of Cochrane producing trusted evidence.

What is growth monitoring and promotion?

During October 2023, the CIDG contributed to one new Cochrane Review in Issue 10, 2023 of the Cochrane Database of Systematic Reviews.New review